Active federal lawsuit (Lehrman & Sage v. Lovo, Inc., SDNY) over voice cloning without consent is the top risk — signals potential deficiency in consent management and data handling practices. Broad R&D carve-out allows use of your voice data beyond your specific project. SOC 2 audit still in progress at time of research. Outputs may have clouded IP status while litigation is pending.
Monitor the Lehrman & Sage litigation outcome for IP clarity. Do not use LOVO for high-value biometric voice projects until SOC 2 Type II is confirmed. Review and negotiate enterprise DPA if possible. Avoid submitting voices of recognizable individuals. Demand written confirmation of data deletion upon account closure.